Therapeutic options for elderly patients with advanced non-small cell lung cancer

Eric J. Avery, Anne Kessinger, Apar Kishor P Ganti

Research output: Contribution to journalReview article

18 Citations (Scopus)

Abstract

Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)340-344
Number of pages5
JournalCancer Treatment Reviews
Volume35
Issue number4
DOIs
StatePublished - Jun 1 2009

Fingerprint

Non-Small Cell Lung Carcinoma
Therapeutics
Morbidity
Survival

Keywords

  • Elderly
  • NSCLC
  • Non-small cell lung cancer
  • Treatment

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Therapeutic options for elderly patients with advanced non-small cell lung cancer. / Avery, Eric J.; Kessinger, Anne; Ganti, Apar Kishor P.

In: Cancer Treatment Reviews, Vol. 35, No. 4, 01.06.2009, p. 340-344.

Research output: Contribution to journalReview article

@article{016af3d8cd794adeba42baed228e358b,
title = "Therapeutic options for elderly patients with advanced non-small cell lung cancer",
abstract = "Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer.",
keywords = "Elderly, NSCLC, Non-small cell lung cancer, Treatment",
author = "Avery, {Eric J.} and Anne Kessinger and Ganti, {Apar Kishor P}",
year = "2009",
month = "6",
day = "1",
doi = "10.1016/j.ctrv.2008.10.008",
language = "English (US)",
volume = "35",
pages = "340--344",
journal = "Cancer Treatment Reviews",
issn = "0305-7372",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Therapeutic options for elderly patients with advanced non-small cell lung cancer

AU - Avery, Eric J.

AU - Kessinger, Anne

AU - Ganti, Apar Kishor P

PY - 2009/6/1

Y1 - 2009/6/1

N2 - Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer.

AB - Elderly patients with advanced non-small cell lung cancer (NSCLC) are at higher risk for adverse events related to treatment of their disease. Chemotherapeutic agents used alone or together may increase survival, while leading to increased treatment related morbidity. New targeted agents used to treat NSCLC have yet to show sufficient improvement in disease outcomes. This review will discuss the current management of elderly patients with advanced non-small cell lung cancer.

KW - Elderly

KW - NSCLC

KW - Non-small cell lung cancer

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=67349223561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67349223561&partnerID=8YFLogxK

U2 - 10.1016/j.ctrv.2008.10.008

DO - 10.1016/j.ctrv.2008.10.008

M3 - Review article

C2 - 19155139

AN - SCOPUS:67349223561

VL - 35

SP - 340

EP - 344

JO - Cancer Treatment Reviews

JF - Cancer Treatment Reviews

SN - 0305-7372

IS - 4

ER -